These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 27245314)
1. Anti Myelin-Associated-Glycoprotein Antibody Peripheral Neuropathy Response to Combination Chemoimmunotherapy With Bendamustine/Rituximab in a Patient With Biclonal IgM κ and IgM λ: Case Report and Review of the Literature. Gomez A; Hoffman JE Clin Lymphoma Myeloma Leuk; 2016 Jul; 16(7):e101-8. PubMed ID: 27245314 [No Abstract] [Full Text] [Related]
9. [Anti-myelin-associated glycoprotein antibody positive IgM monoclonal gammopathy related peripheral neuropathy: 11 cases and literature review]. Gao XM; Jia MN; Qian M; Ren HT; Zhang L; Shen KN; Cao XX; Li J Zhonghua Xue Ye Xue Za Zhi; 2019 Nov; 40(11):901-905. PubMed ID: 31856437 [No Abstract] [Full Text] [Related]
10. [Neuropathies associated with monoclonal IgM anti-MAG antibodies]. Pihan M; Decaux O; Marcorelles P; Bahon-Riedinger I; Lemercier S; Gainche-Salmon A; Doncker AV Rev Med Interne; 2012 Dec; 33(12):686-92. PubMed ID: 22726239 [TBL] [Abstract][Full Text] [Related]
11. Deterioration of tremor after treatment with rituximab in anti-MAG neuropathy. Doneddu PE; Kazmi M; Samuel M; Mahdi-Rogers M; Hadden RDM J Neurol Sci; 2017 Feb; 373():344-345. PubMed ID: 28131219 [No Abstract] [Full Text] [Related]
12. Rituximab treatment of an IgM monoclonal autonomic and sensory neuropathy. Goldfarb AR; Weimer LH; Brannagan TH Muscle Nerve; 2005 Apr; 31(4):510-5. PubMed ID: 15685616 [TBL] [Abstract][Full Text] [Related]
13. IgM MGUS and Waldenstrom-associated anti-MAG neuropathies display similar response to rituximab therapy. Campagnolo M; Zambello R; Nobile-Orazio E; Benedetti L; Marfia GA; Riva N; Castellani F; Bianco M; Salvalaggio A; Garnero M; Ruiz M; Mataluni G; Fazio R; Ermani M; Briani C J Neurol Neurosurg Psychiatry; 2017 Dec; 88(12):1094-1097. PubMed ID: 28501820 [No Abstract] [Full Text] [Related]
15. [Detection of antibodies binding to myelin in 75 neuropathies associated with IgM gammopathy]. Campant RM; Caudie C; Kopp N; Lombard C; Later R Ann Biol Clin (Paris); 1999; 57(1):69-75. PubMed ID: 9920969 [TBL] [Abstract][Full Text] [Related]
16. Axonal loss influences the response to rituximab treatment in neuropathy associated with IgM monoclonal gammopathy with anti-myelin-associated glycoprotein antibody. Kawagashira Y; Koike H; Ohyama K; Hashimoto R; Iijima M; Adachi H; Katsuno M; Chapman M; Lunn M; Sobue G J Neurol Sci; 2015 Jan; 348(1-2):67-73. PubMed ID: 25467141 [TBL] [Abstract][Full Text] [Related]
17. The human anti-myelin-associated glycoprotein IgM system. Murray N; Page N; Steck AJ Ann Neurol; 1986 May; 19(5):473-8. PubMed ID: 2424361 [TBL] [Abstract][Full Text] [Related]
18. Bendamustine plus rituximab versus fludarabine plus rituximab for patients with relapsed indolent and mantle-cell lymphomas: a multicentre, randomised, open-label, non-inferiority phase 3 trial. Rummel M; Kaiser U; Balser C; Stauch M; Brugger W; Welslau M; Niederle N; Losem C; Boeck HP; Weidmann E; von Gruenhagen U; Mueller L; Sandherr M; Hahn L; Vereshchagina J; Kauff F; Blau W; Hinke A; Barth J; Lancet Oncol; 2016 Jan; 17(1):57-66. PubMed ID: 26655425 [TBL] [Abstract][Full Text] [Related]
19. Long-term response to rituximab and fludarabine combination in IgM anti-myelin-associated glycoprotein neuropathy. Gruson B; Ghomari K; Beaumont M; Garidi R; Just A; Merle P; Merlusca L; Marolleau JP; Royer B J Peripher Nerv Syst; 2011 Sep; 16(3):180-5. PubMed ID: 22003932 [TBL] [Abstract][Full Text] [Related]
20. Waldenström macroglobulinemia: 2017 update on diagnosis, risk stratification, and management. Gertz MA Am J Hematol; 2017 Feb; 92(2):209-217. PubMed ID: 28094456 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]